Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,515 | 121 | 98.7% |
| Education | $19.78 | 4 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $243.83 | 33 | $0 (2018) |
| PFIZER INC. | $117.14 | 9 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $111.38 | 8 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $100.22 | 8 | $0 (2018) |
| Novo Nordisk Inc | $85.26 | 6 | $0 (2020) |
| Genentech USA, Inc. | $82.25 | 5 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $57.03 | 4 | $0 (2020) |
| Amarin Pharma Inc. | $56.56 | 4 | $0 (2020) |
| Lilly USA, LLC | $49.07 | 4 | $0 (2022) |
| DePuy Synthes Sales Inc. | $45.89 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.23 | 1 | Philips North America LLC ($19.23) |
| 2023 | $17.97 | 1 | Medtronic, Inc. ($17.97) |
| 2022 | $11.71 | 1 | Lilly USA, LLC ($11.71) |
| 2021 | $33.77 | 2 | Teva Pharmaceuticals USA, Inc. ($18.62) |
| 2020 | $432.95 | 29 | Amarin Pharma Inc. ($56.56) |
| 2019 | $241.09 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($41.64) |
| 2018 | $327.50 | 32 | Merck Sharp & Dohme Corporation ($108.20) |
| 2017 | $450.91 | 42 | Merck Sharp & Dohme Corporation ($135.63) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 3 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/07/2019 | Promius Pharma LLC | ZEMBRACE SYMTOUCH (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Neurology | ||||||
| 12/21/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Virology & Specialty Care | ||||||
| 11/30/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/16/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/02/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Virology & Specialty Care | ||||||
| 10/24/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, STEGLATRO | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/10/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/25/2018 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $11.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/21/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, STEGLATRO | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/18/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, STEGLATRO | Food and Beverage | In-kind items and services | $1.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/07/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/05/2018 | FIDIA PHARMA USA INC. | HYALGAN (Device), HYMOVIS | Food and Beverage | Cash or cash equivalent | $11.36 | General |
| Category: OSTEOARTHRITIS | ||||||
| 08/28/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Central Nervous System (CNS) | ||||||
| 08/09/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $2.83 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/08/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), ASMANEX, STEGLATRO | Food and Beverage | In-kind items and services | $8.10 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/10/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $8.88 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/22/2018 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Respiratory | ||||||
| 06/01/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $6.49 | General |
| 05/11/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/30/2018 | Sunovion Pharmaceuticals Inc. | Utibron (Drug), Seebri, Lonhala Magnair | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Respiratory | ||||||
| 04/18/2018 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Diabetes | ||||||
| 04/03/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 49 | 4,087 | 10,518 | $908,217 | $283,542 |
| 2022 | 42 | 3,883 | 10,583 | $974,577 | $302,538 |
| 2021 | 44 | 4,079 | 10,670 | $1.0M | $312,613 |
| 2020 | 46 | 4,441 | 11,910 | $1.1M | $323,609 |
All Medicare Procedures & Services
181 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 292 | 919 | $254,563 | $78,407 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 211 | 574 | $107,912 | $34,828 | 32.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 254 | 254 | $58,420 | $31,041 | 53.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 134 | 621 | $40,986 | $26,631 | 65.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 49 | 218 | $48,178 | $12,878 | 26.7% |
| 71045 | X-ray of chest, 1 view | Office | 2023 | 265 | 527 | $26,350 | $9,712 | 36.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 302 | 875 | $49,000 | $8,740 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 301 | 867 | $11,271 | $7,258 | 64.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 131 | 154 | $30,184 | $6,787 | 22.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 277 | 415 | $42,330 | $5,432 | 12.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 40 | $14,920 | $5,146 | 34.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $4,535 | $4,445 | 98.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 129 | 439 | $32,925 | $4,364 | 13.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 64 | 66 | $18,546 | $3,559 | 19.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 40 | 55 | $12,210 | $3,353 | 27.5% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 39 | 55 | $9,075 | $3,274 | 36.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 292 | 918 | $11,016 | $3,122 | 28.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 46 | 76 | $13,604 | $3,109 | 22.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 31 | 35 | $9,170 | $3,046 | 33.2% |
| 70210 | X-ray of paranasal sinus, 1-2 views | Office | 2023 | 81 | 135 | $9,045 | $3,007 | 33.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 44 | 59 | $6,490 | $2,365 | 36.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 118 | 118 | $5,270 | $2,052 | 38.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $13,377 | $1,910 | 14.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $5,544 | $1,721 | 31.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 83 | 86 | $6,192 | $1,545 | 24.9% |
About Dr. Stephen Williams, M.D
Dr. Stephen Williams, M.D is a Family Medicine healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679530505.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Williams, M.D has received a total of $1,535 in payments from pharmaceutical and medical device companies, with $19.23 received in 2024. These payments were reported across 125 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($1,515).
As a Medicare-enrolled provider, Williams has provided services to 16,490 Medicare beneficiaries, totaling 43,681 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 181 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Omaha, NE
- Active Since 04/26/2006
- Last Updated 01/11/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1679530505
Products in Payments
- JANUVIA (Drug) $156.81
- Xofluza (Drug) $82.25
- CHANTIX (Drug) $81.48
- JARDIANCE (Drug) $68.13
- Vascepa (Drug) $56.56
- Utibron (Drug) $54.56
- BELSOMRA (Drug) $49.66
- ORTHOVISC (Device) $45.89
- UTIBRON (Drug) $45.66
- Ozempic (Drug) $44.03
- STIOLTO RESPIMAT (Drug) $43.25
- Victoza (Drug) $41.23
- NUEDEXTA (Drug) $40.90
- ZEMBRACE SYMTOUCH (Drug) $39.49
- UBRELVY (Drug) $36.06
- FARXIGA (Drug) $32.95
- TRELEGY ELLIPTA (Drug) $29.37
- XIFAXAN (Drug) $26.64
- ENTRESTO (Drug) $26.03
- WELLBUTRIN (Drug) $26.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Omaha
Dr. Gerard Stanley, M.d, M.D
Family Medicine — Payments: $49,779
M. Dada, M.d., Ph.d, M.D., PH.D
Family Medicine — Payments: $14,443
Dr. Yongge Liu, M.d, M.D
Family Medicine — Payments: $13,977
Christopher Connolly, M.d, M.D
Family Medicine — Payments: $11,989
Christopher Beasley, Pa-C, PA-C
Family Medicine — Payments: $11,635
Joseph Dumba, M.d, M.D
Family Medicine — Payments: $10,949